Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-03-22 @ 1:36 PM
Study NCT ID:
NCT00333502
Status:
COMPLETED
Last Update Posted:
2020-05-28
First Post:
2006-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
Sponsor:
NewLink Genetics Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CRLX-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None